Mining disproportional frequent arrangements of event intervals for investigating adverse drug events

被引:2
|
作者
Lee, Zed [1 ]
Rebane, Jonathan [1 ]
Papapetrou, Panagiotis [1 ]
机构
[1] Stockholm Univ, Dept Comp & Syst Sci, Stockholm, Sweden
来源
2020 IEEE 33RD INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS(CBMS 2020) | 2020年
基金
瑞典研究理事会;
关键词
machine learning; temporal intervals; adverse drug events; PATIENT;
D O I
10.1109/CBMS49503.2020.00061
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Adverse drug events are pervasive and costly medical conditions, in which novel research approaches are needed to investigate the nature of such events further and ultimately achieve early detection and prevention. In this paper, we seek to characterize patients who experience an adverse drug event, represented as a case group, by contrasting them to similar control group patients who do not experience such an event. To achieve this goal, we utilize an extensive electronic patient record database and apply a combination of frequent arrangement mining and disproportionality analysis. Our results have identified how several adverse drug events are characterized in regards to frequent disproportional arrangements, where we highlight how such arrangements can provide additional temporal-based information compared to similar approaches.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 50 条
  • [41] Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system
    Zhao, Bangyao
    Zhao, Lili
    STATISTICS IN MEDICINE, 2023, 42 (10) : 1512 - 1524
  • [42] Adverse events reported to the US Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
    Dores, Graca M.
    Jason, Christopher
    Niu, Manette T.
    Perez-Vilar, Silvia
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1087 - 1100
  • [43] Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
    Roitmann, Eva
    Eriksson, Robert
    Brunak, Soren
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [44] Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System
    James R. Rogers
    Ameet Sarpatwari
    Rishi J. Desai
    Justin M. Bohn
    Nazleen F. Khan
    Aaron S. Kesselheim
    Michael A. Fischer
    Joshua J. Gagne
    John G. Connolly
    Drug Safety, 2019, 42 : 85 - 93
  • [45] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Wei, Lianhui
    Tian, Ye
    Chen, Xiao
    Guo, Xiaojing
    Chen, Chenxin
    Zheng, Yi
    Xu, Jinfang
    Ye, Xiaofei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 622 - 629
  • [46] Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database
    Umetsu, Ryogo
    Abe, Junko
    Ueda, Natsumi
    Kato, Yamato
    Nakayama, Yoko
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (08): : 991 - 1000
  • [47] Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the US Food and Drug Administration Adverse Event Reporting System
    Kadoyama, Kaori
    Sakaeda, Toshiyuki
    Tamon, Akiko
    Okuno, Yasushi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (06) : 967 - 970
  • [48] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [49] Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS
    Sun, Ji
    Deng, Xuanyu
    Huang, Juanjuan
    He, Gefei
    Huang, Shiqiong
    PLOS ONE, 2024, 19 (12):
  • [50] Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
    Federer, Callie
    Yoo, Minjae
    Tan, Aik Choon
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2016, 14 (10) : 357 - 366